| Secondary |
| Drug Use For Unknown Indication |
24.1% |
| Depression |
14.2% |
| Product Used For Unknown Indication |
10.4% |
| Hypertension |
7.5% |
| Pain |
7.5% |
| Psoas Abscess |
5.7% |
| Breast Cancer |
3.8% |
| Drug Exposure During Pregnancy |
3.8% |
| Plasmacytoma |
3.3% |
| Abdominal Pain |
2.8% |
| Diabetes Mellitus |
2.8% |
| Gastritis |
2.8% |
| Premedication |
2.8% |
| Hyperthyroidism |
1.9% |
| Back Pain |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Chemotherapy |
0.9% |
| Erythropenia |
0.9% |
| Hyperglycaemia |
0.9% |
| Hypothyroidism |
0.9% |
|
| Restless Legs Syndrome |
13.3% |
| Restlessness |
13.3% |
| Foetal Growth Retardation |
8.9% |
| Pulmonary Embolism |
8.9% |
| Cerebrovascular Disorder |
6.7% |
| Tremor |
6.7% |
| Delirium |
4.4% |
| Pruritus |
4.4% |
| Somnolence |
4.4% |
| Stevens-johnson Syndrome |
4.4% |
| Toxic Epidermal Necrolysis |
4.4% |
| Dyskinesia |
2.2% |
| Eye Movement Disorder |
2.2% |
| Fall |
2.2% |
| Femoral Neck Fracture |
2.2% |
| Femur Fracture |
2.2% |
| Mixed Liver Injury |
2.2% |
| Myoclonus |
2.2% |
| Neurotoxicity |
2.2% |
| Off Label Use |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.4% |
| Pain |
11.4% |
| Hypertension |
10.1% |
| Rheumatoid Arthritis |
6.6% |
| Depression |
5.3% |
| Drug Use For Unknown Indication |
3.6% |
| Tumour Pain |
3.2% |
| Constipation |
3.1% |
| Prophylaxis |
2.8% |
| Coronary Artery Disease |
2.7% |
| Non-small Cell Lung Cancer |
2.3% |
| Thrombosis Prophylaxis |
2.0% |
| Diabetes Mellitus |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Neuralgia |
1.5% |
| Colorectal Cancer Metastatic |
1.4% |
| Peripheral T-cell Lymphoma Unspecified |
1.4% |
| Sleep Disorder |
1.4% |
| Attention Deficit/hyperactivity Disorder |
1.1% |
| Bone Pain |
1.1% |
|
| Pulmonary Embolism |
10.7% |
| Agranulocytosis |
7.1% |
| Hypertension |
7.1% |
| Libido Increased |
7.1% |
| Death |
5.4% |
| Dehydration |
5.4% |
| Pneumonia |
5.4% |
| Renal Failure Acute |
5.4% |
| Urine Output Decreased |
5.4% |
| Vomiting |
5.4% |
| General Physical Health Deterioration |
3.6% |
| Headache |
3.6% |
| Off Label Use |
3.6% |
| Plastic Surgery |
3.6% |
| Pseudomonas Infection |
3.6% |
| Pyrexia |
3.6% |
| Respiratory Failure |
3.6% |
| Shunt Thrombosis |
3.6% |
| Somnolence |
3.6% |
| Suicide Attempt |
3.6% |
|
| Interacting |
| Personality Disorder |
75.0% |
| Depression |
15.0% |
| Depressive Delusion |
5.0% |
| Major Depression |
5.0% |
|
| Drug Interaction |
30.0% |
| Weight Decreased |
30.0% |
| Somnolence |
20.0% |
| Potentiating Drug Interaction |
10.0% |
| Tardive Dyskinesia |
10.0% |
|
